先看重点
在纳入46项记录的伞状综述中,远程医疗与糖尿病患者糖化血红蛋白(HbA1c)降低至少0.5%的临床相关改善相关,新近诊断者和基线高于8%者降幅更大。对血压未见显著且有临床意义的作用,证据质量为低至极低。
证据类型
综述的综述
解读依据
公开摘要
阅读重点
方法与适用范围
研究在问什么
远程医疗被认为能改善慢性病管理和自我管理,但糖尿病、高血压和血脂异常的现行指南,并未就哪些远程医疗成分对哪类患者最有效给出循证建议。研究者旨在收集、综合并评价远程医疗临床效果的证据。
研究了谁,如何研究
对随机对照试验的系统评价和荟萃分析进行伞状综述,检索PubMed、EMBASE和Cochrane图书馆。两名作者独立筛选研究、提取数据并评价质量。在3564条文献中纳入46条记录。按预先设定的临床相关性阈值,依据干预成分和患者特征整理结果,并用GRADE评价总体证据确定性。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 1在糖尿病患者中,远程医疗使糖化血红蛋白(HbA1c)出现显著且有临床意义的下降,幅度至少0.5%(即降低0.5个百分点或更多)。
- 2新近诊断者和基线HbA1c高于8%者的降幅更大。
- 3远程医疗对血压没有显著且有临床意义的影响。
- 4仅找到报告糖尿病患者血脂结局的综述,因此无法单独评价血脂异常。GRADE评定总体证据质量为低至极低。
局限与不确定性
- 1GRADE证据确定性为低至极低,真实效应可能与这些估计值相差很大。
- 2远程医疗包含许多不同的工具,平均结果掩盖了干预之间的巨大差异,亚组结论所依据的综述更少。
- 3纳入的综述多发表于2015年之后,其底层试验可能有重叠,摘要未说明如何处理。本文解读仅基于摘要。
对日常健康的启示
对糖尿病患者来说,远程监测和指导项目可能有助于降低HbA1c,尤其是在刚确诊或水平较高时,但证据较弱。对血压,汇总证据未显示明确获益。是否对某种疾病使用远程医疗,应由你的诊疗团队决定。
如何联系自己的数据
远程项目通常依赖你已在记录的数据,例如连续血糖监测或血糖仪读数、家庭血压和体重。请提供同一设备、相同条件下的连续记录,并关注数周的趋势。
如何理解这类证据
多篇综述可能反复使用同一试验,篇数不等于独立重复验证次数;应看质量、重叠和各结局的确定性。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Background
Telemedicine is defined by three characteristics: (1) using information and communication technologies, (2) covering a geographical distance, and (3) involving professionals who deliver care directly to a patient or a group of patients. It is said to improve chronic care management and self-management in patients with chronic diseases. However, currently available guidelines for the care of patients with diabetes, hypertension, or dyslipidemia do not include evidence-based guidance on which components of telemedicine are most effective for which patient populations.
Objective
The primary aim of this study was to identify, synthesize, and critically appraise evidence on the effectiveness of telemedicine solutions and their components on clinical outcomes in patients with diabetes, hypertension, or dyslipidemia.
Methods
We conducted an umbrella review of high-level evidence, including systematic reviews and meta-analyses of randomized controlled trials. On the basis of predefined eligibility criteria, extensive automated and manual searches of the databases PubMed, EMBASE, and Cochrane Library were conducted. Two authors independently screened the studies, extracted data, and carried out the quality assessments. Extracted data were presented according to intervention components and patient characteristics using defined thresholds of clinical relevance. Overall certainty of outcomes was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tool.
Results
Overall, 3564 references were identified, of which 46 records were included after applying eligibility criteria. The majority of included studies were published after 2015. Significant and clinically relevant reduction rates for glycated hemoglobin (HbA_(1c); ≤-0.5%) were found in patients with diabetes. Higher reduction rates were found for recently diagnosed patients and those with higher baseline HbA_(1c) (>8%). Telemedicine was not found to have a significant and clinically meaningful impact on blood pressure. Only reviews or meta-analyses reporting lipid outcomes in patients with diabetes were found. GRADE assessment revealed that the overall quality of the evidence was low to very low.
Conclusions
The results of this umbrella review indicate that telemedicine has the potential to improve clinical outcomes in patients with diabetes. Although subgroup-specific effectiveness rates favoring certain intervention and population characteristics were found, the low GRADE ratings indicate that evidence can be considered as limited. Future updates of clinical care and practice guidelines should carefully assess the methodological quality of studies and the overall certainty of subgroup-specific outcomes before recommending telemedicine interventions for certain patient populations.
来源与署名
Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses.
Timpel P, Oswald S, Schwarz PEH, Harst L.
Journal of medical Internet research · 2020-03-18
DOI: 10.2196/16791 ↗PubMed · 32186516 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
昼夜活动节律紊乱与更高的死亡风险相关(109,365人)
在7项观察性研究、共109,365名参与者中,昼夜活动对比较弱(相对振幅较低)与更高的心血管死亡风险(风险比[HR]1.50,95%置信区间1.13至1.98)和全因死亡风险(HR 1.46,95%置信区间1.27至1.68)相关。证据基础小,又是观察性的,不能说明改善节律就能降低风险,疾病本身也可能扰乱节律。
Journal of the American Heart Association
五类运动都降低了静息血压,等长训练降幅最大
汇总270项随机试验、共15,827名参与者的结果,有氧、抗阻、联合、间歇和等长训练与无干预对照组相比都降低了静息血压(各P<0.001),其中等长训练降幅最大:收缩压下降8.24 mm Hg,舒张压下降4.00 mm Hg。各方式之间的排序部分来自间接比较,各试验也不尽相同,所以排序不是个人的运动处方。
British Journal of Sports Medicine
盐替代品使中国农村高危人群的卒中、主要心血管事件和死亡率下降
在中国农村600个村庄、20,995名有卒中史或年龄在60岁及以上且有高血压的人中,使用盐替代品(氯化钠75%、氯化钾25%)的卒中发生率低于普通盐:平均随访4.74年,每1000人年29.14次对33.65次(率比0.86,95%置信区间0.77至0.96;P=0.006)。死亡也更低(率比0.88),严重高钾血症事件没有显著增多,但试验为开放标签设计,且在中国农村开展。
The New England Journal of Medicine
智能手表脉搏不规则提醒较少见,做贴片检查者34%确有房颤
在419,297名没有已知心房颤动(房颤)的苹果手表用户中,0.52%收到脉搏不规则提醒;返还可用心电贴片的450人中,34%确认有房颤(97.5%置信区间29至39)。提醒发出时恰有贴片记录的,通知的阳性预测值为0.84(95%置信区间0.76至0.92),但收到提醒者中仅20.8%返还了贴片,没有收到提醒的人未被监测,所以手表没有提醒并不能排除房颤。
The New England Journal of Medicine

